Biofrontera AG | Mutual Funds
Mutual Funds that own Biofrontera AG
MOZART One
976,311
2.19%
411,178
7.96%
12/31/2017
Akrobat Fund - Europa
961,315
2.16%
0
2.54%
12/31/2017
Lupus alpha Fonds - Smaller German Champions
258,152
0.57%
0
0.27%
12/31/2017
Lupus alpha Fonds - Micro Champions
240,000
0.54%
0
3.29%
12/31/2017
Multiadvisor SICAV - Esprit
100,000
0.23%
0
0.83%
12/31/2017
Multiadvisor SICAV - Privat Invest
54,000
0.12%
0
1.7%
12/31/2017
Primus Inter Pares Strategie Chance
46,896
0.11%
0
5.51%
09/30/2017
Hector SICAV - Fide Growth
32,391
0.07%
0
3.16%
09/27/2017
ICMetzner Portfolio - Select
24,000
0.05%
645
1.61%
12/31/2017
Tury Vermoegensverwaltung
22,579
0.05%
-7,500
1.07%
06/30/2018
| Address |
Hemmelrather Weg 201
Leverkusen Nordrhein-Westfalen 51377
Germany
|
|
Employees
|
- |
| Website |
http://biofrontera.com |
| Updated |
07/08/2019 |
| Biofrontera AG is a biopharmaceutical company, which engages in the development, sale, and distribution of dermatological drugs and medical cosmetics for the care, protection, and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria, and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany. |
